ACCESSION: MSBNK-SMB_Measured-HSA032P0246008
RECORD_TITLE: Characterized; Glutaminylvaline; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 10
COMMENT: RAW_SPEC {'RA26-pos_1133': {'bp': 1291.0, 'sum': 4410.0}, 'QC3-pos_1169': {'bp': 1099.0, 'sum': 5547.0}, 'HC15-pos_1203': {'bp': 1060.0, 'sum': 5060.0}, 'HC19-pos_1155': {'bp': 932.0, 'sum': 4089.0}, 'HC8-pos_1160': {'bp': 888.0, 'sum': 3286.0}, 'HC3-pos_1295': {'bp': 877.0, 'sum': 5067.0}, 'HC3-pos_1256': {'bp': 796.0, 'sum': 3753.0}, 'RA17-pos_1080': {'bp': 755.0, 'sum': 3181.0}, 'RA9-pos_1085': {'bp': 373.0, 'sum': 2235.0}, 'HC19-pos_1102': {'bp': 342.0, 'sum': 1835.0}}
COMMENT: RETENTION_TIME_STDEV 0.037
COMMENT: PRECURSOR_M/Z_RAW 246.143283
COMMENT: PRECURSOR_M/Z_STDEV 0.000701
COMMENT: PRECURSOR_IN_MS1 mz 246.143856; int 116.036; delta(ppm) 11.474911
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 10.574; C8H24NO5P; [M+H]+; delta(ppm) -10.573696
COMMENT: PROPOSED_MF SevenGoldenRules 3.835; C10H19N3O4; [M+H]+; delta(ppm) -3.834596
COMMENT: PROPOSED_MF SevenGoldenRules 13.384; C15H20NP; [M+H]+; delta(ppm) 13.384373
COMMENT: PROPOSED_MF MS-FINDER 3.891; C10H19N3O4; [M+H]+; delta(ppm) -3.821117
COMMENT: PROPOSED_MF MS-FINDER 2.885; C6H23N5OS2; [M+H]+; delta(ppm) 8.991470
COMMENT: PROPOSED_MF MS-FINDER 2.801; C6H15N9O2; [M+H]+; delta(ppm) 7.088502
COMMENT: PROPOSED_MF MS-FINDER 2.390; C11H15N7; [M+H]+; delta(ppm) -9.254510
COMMENT: PROPOSED_MF SIRIUS5_Sirius 18.871; C10H19N3O4; [M+H]+; delta(ppm) -3.821117
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H19N3O4; [M+H]+; delta(ppm) -3.821117
COMMENT: PROPOSED_MF SIRIUS6_Sirius 30.845; C10H19N3O4; [M+H]+; delta(ppm) -3.821117
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.395; C8H18F3N3O2; [M+H]+; delta(ppm) 6.113241
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.987; C10H20FN3OSi; [M+H]+; delta(ppm) -206211.208368
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.609; C11H15N7; [M+H]+; delta(ppm) -9.254510
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.371; C8H17N6O3; [M+H]+; delta(ppm) 1.633663
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.291; C6H15N9O2; [M+H]+; delta(ppm) 7.088502
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.558; C13H16BFN2O; [M+H]+; delta(ppm) 42399.809664
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.321; C16H15BN2; [M+H]+; delta(ppm) 42404.853911
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.879; C11H24NOPSi; [M+H]+; delta(ppm) -206212.511638
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.144; C13H19N3Si; [M+H]+; delta(ppm) -206208.283292
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H19N3O4; [M+H]+; delta(ppm) -3.821117
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.636; MRVYVEQPNDSWLH-BTBXXMRTNA-N; [M+H]+; CC(C)[C@H](NC(=O)[C@@H](N)CCC(N)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.483; XXDVDTMEVBYRPK-UHFFFAOYNA-N; [M+H]+; CC(C)C(N)C(=O)NC(CCC(N)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.348; RNVIUPLZMWAIQD-UHFFFAOYNA-N; [M+H]+; CC(C)C(N)C(=O)NC(=O)CCC(N)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.336; PTOIAAWZLUQTIO-KQKSKQCLNA-N; [M+H]+; CCC(=O)NC[C@@H]1C[C@H]1C1=CC=CC2=C1CCO2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.194; OGJNMISUIGRWIJ-UHFFFAOYSA-N; [M+H]+; O=C1OC(C)(CC)C2(C=3C=CC=CC3CCN12)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.538; WBRUPBYQJCBBBL-UHFFFAOYSA-N; [M+H]+; 2-[4-(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.374; XXDVDTMEVBYRPK-UHFFFAOYNA-N; [M+H]+; Valyl-Glutamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.334; CGADBKNPQUQOIP-UHFFFAOYSA-N; [M+H]+; N-[(4-amino-3-hydroxyoxolan-2-yl)methyl]morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.218; RNVIUPLZMWAIQD-UHFFFAOYNA-N; [M+H]+; Valyl-Gamma-glutamate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.215; MRVYVEQPNDSWLH-BTBXXMRTNA-N; [M+H]+; Glutaminylvaline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.197; HZYHBDVRCBDJJV-UHFFFAOYNA-N; [M+H]+; Isoleucyl-Asparagine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.149; QNBHZXFGRLNYRY-UHFFFAOYSA-N; [M+H]+; [4-[(2-amino-2-methylpropanoyl)amino]cyclohexyl] nitrate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.099; VWHGTYCRDRBSFI-ZETCQYMHSA-N; [M+H]+; Leu-Gly-Gly
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.069; MQLZLIYPFDIDMZ-UHFFFAOYNA-N; [M+H]+; Asparaginyl-Isoleucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.015; XPJBQTCXPJNIFE-SSDOTTSWSA-N; [M+H]+; Gly-Gly-D-Leu
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.984; XMPXVJIDADUOQB-RCOVLWMOSA-N; [M+H]+; Gly-Gly-Ile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.944; MLTRLIITQPXHBJ-UHFFFAOYNA-N; [M+H]+; Leucyl-Asparagine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.892; HXWUJJADFMXNKA-UHFFFAOYNA-N; [M+H]+; Asparaginyl-Leucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; QNBHZXFGRLNYRY-UHFFFAOYSA-N; [M+H]+; [4-[(2-amino-2-methylpropanoyl)amino]cyclohexyl] nitrate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.992; RNVIUPLZMWAIQD-UHFFFAOYNA-N; [M+H]+; Valyl-Gamma-glutamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.949; XXDVDTMEVBYRPK-UHFFFAOYNA-N; [M+H]+; Valyl-Glutamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.902; MRVYVEQPNDSWLH-BTBXXMRTNA-N; [M+H]+; Glutaminylvaline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.853; WBRUPBYQJCBBBL-UHFFFAOYSA-N; [M+H]+; 2-[4-(carboxymethyl)-1,4,7-triazonan-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.647; HZYHBDVRCBDJJV-UHFFFAOYNA-N; [M+H]+; Isoleucyl-Asparagine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.458; MLTRLIITQPXHBJ-UHFFFAOYNA-N; [M+H]+; Leucyl-Asparagine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.458; VWHGTYCRDRBSFI-ZETCQYMHSA-N; [M+H]+; Leu-Gly-Gly
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.339; CGADBKNPQUQOIP-UHFFFAOYSA-N; [M+H]+; N-[(4-amino-3-hydroxyoxolan-2-yl)methyl]morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.313; HXWUJJADFMXNKA-UHFFFAOYNA-N; [M+H]+; Asparaginyl-Leucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.313; MQLZLIYPFDIDMZ-UHFFFAOYNA-N; [M+H]+; Asparaginyl-Isoleucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.313; XMPXVJIDADUOQB-RCOVLWMOSA-N; [M+H]+; Gly-Gly-Ile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.313; XPJBQTCXPJNIFE-SSDOTTSWSA-N; [M+H]+; Gly-Gly-D-Leu
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.962; MLTRLIITQPXHBJ-UHFFFAOYSA-N; [M+H]+; 4-amino-2-[(2-amino-4-methylpentanoyl)amino]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.445; XXDVDTMEVBYRPK-XPUUQOCRSA-N; [M+H]+; (2S)-5-amino-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.891; HXWUJJADFMXNKA-UHFFFAOYSA-N; [M+H]+; 2-[(2,4-diamino-4-oxobutanoyl)amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.801; XMPXVJIDADUOQB-RCOVLWMOSA-N; [M+H]+; (2S,3S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; RNVIUPLZMWAIQD-UHFFFAOYSA-N; [M+H]+; 2-amino-5-[(2-amino-3-methylbutanoyl)amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.319; HZYHBDVRCBDJJV-UHFFFAOYSA-N; [M+H]+; 4-amino-2-[(2-amino-3-methylpentanoyl)amino]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.244; MRVYVEQPNDSWLH-XPUUQOCRSA-N; [M+H]+; (2S)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; MQLZLIYPFDIDMZ-HAFWLYHUSA-N; [M+H]+; (2S,3S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.796; VWHGTYCRDRBSFI-UHFFFAOYSA-N; [M+H]+; 2-[[2-[(2-amino-4-methylpentanoyl)amino]acetyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; YDNSBSUBUKQVIV-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(hydrazinecarbonyl)morpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.739; XSXVXWAWKDJTCF-UHFFFAOYSA-N; [M+H]+; tert-butyl 2-[(Z)-N'-hydroxycarbamimidoyl]morpholine-4-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -9.041; MRVYVEQPNDSWLH; [M+H]+; 2-[(2,5-diamino-5-oxopentanoyl)amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -38.182; XXDVDTMEVBYRPK; [M+H]+; Valylglutamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -142.666; HXWUJJADFMXNKA; [M+H]+; 2-[(2,4-diamino-4-oxobutanoyl)amino]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.832; JRDYDYXZKFNNRQ; [M+H]+; ACMC-20mphf
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.346; RNVIUPLZMWAIQD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -156.271; MLTRLIITQPXHBJ; [M+H]+; L-leucyl-L-asparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.520; MQLZLIYPFDIDMZ; [M+H]+; 2-[(2,4-diamino-4-oxobutanoyl)amino]-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.797; ASQFIHTXXMFENG; [M+H]+; Glycine, N-(N-L-valyl-L-alanyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.175; HZYHBDVRCBDJJV; [M+H]+; isoleucylasparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.350; VWHGTYCRDRBSFI; [M+H]+; Leucylglycylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.523; XPJBQTCXPJNIFE; [M+H]+; glycylglycylleucine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.435; KNBQDLQVANYHFJ; [M+H]+; l-Alanyl-l-alanyl-l-alanine methyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.773; XMPXVJIDADUOQB; [M+H]+; glycylglycylisoleucine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.233; XDWLTSFLMBTXSP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.822; CCBIBMKQNXHNIN; [M+H]+; glycylleucylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.178; QNBHZXFGRLNYRY; [M+H]+; 2-Amino-2-methyl-N-(4-nitroxycyclohexyl)propionamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -394.545; AKEANMAEJCWJFI; [M+H]+; 2,4-Bis(Acetylamino)-2,4,6-Trideoxy-Beta-D-Glucopyranose
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -456.805; CGADBKNPQUQOIP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.701; MRVYVEQPNDSWLH; [M+H]+; 2-[(2,5-diamino-5-oxopentanoyl)amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.571; MRVYVEQPNDSWLH; [M+H]+; 2-(2-amino-4-carbamoylbutanamido)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -172.045; XXDVDTMEVBYRPK; [M+H]+; 2-(2-amino-3-methylbutanamido)-4-carbamoylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -281.151; JRDYDYXZKFNNRQ; [M+H]+; Glycyl-alanyl-valine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -283.056; SMCGQGDVTPFXKB; [M+H]+; 2-[[2-(2-Aminopropanoylamino)acetyl]amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -291.634; VHAQSYHSDKERBS; [M+H]+; Glycine, L-alanyl-L-valyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -292.978; HXWUJJADFMXNKA; [M+H]+; 2-(2-amino-3-carbamoylpropanamido)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -302.648; ASQFIHTXXMFENG; [M+H]+; 2-[2-[(2-Amino-3-methylbutanoyl)amino]propanoylamino]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -303.270; GWCJMBNBFYBQCV; [M+H]+; 2-[[2-[(2-Aminoacetyl)amino]-3-methylbutanoyl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -305.048; CELJCNRXKZPTCX; [M+H]+; 2-[[2-[(2-Amino-3-methylbutanoyl)amino]acetyl]amino]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -308.952; RNVIUPLZMWAIQD; [M+H]+; Valyl-Gamma-glutamate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.771; MRVYVEQPNDSWLH; [M+H]+; 2-(2-amino-4-carbamoylbutanamido)-3-methylbutanoic acid
COMMENT: CONFIDENCE Level 3: Tentative candidate, Glutaminylvaline, MRVYVEQPNDSWLH-XPUUQOCRSA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (7); This structural isomer was suggested from the biological context HMDB HMDB0028810;
CH$NAME: Glutaminylvaline
CH$NAME: (2S)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]-3-methylbutanoic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C10H19N3O4
CH$EXACT_MASS: 245.137556
CH$SMILES: CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)N
CH$IUPAC: InChI=1S/C10H19N3O4/c1-5(2)8(10(16)17)13-9(15)6(11)3-4-7(12)14/h5-6,8H,3-4,11H2,1-2H3,(H2,12,14)(H,13,15)(H,16,17)/t6-,8-/m0/s1
CH$LINK: INCHIKEY MRVYVEQPNDSWLH-XPUUQOCRSA-N
CH$LINK: PUBCHEM CID:57262456
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.884
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 246.143892
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-9200000000-70b9873e304fdd2af831
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0536770 74.2268 55.053935 21.4155 31.00 0.8716 8 f{C4H7}/-9.98ppm,p-C6H13N3O4
  56.0487789 124.1688 56.049030 16.5927 86.48 0.3179 10 f{C3H6N1}/-12.43ppm,p-C7H14N2O4
  72.0806884 685.8179 72.080846 8.2269 159.42 1.0000 10 f{C4H10N1}/-1.21ppm,p-C6H10N2O4
  83.0603567 935.3143 83.060559 7.6932 127.06 0.8545 10 f{C4H7N2}/-0.22ppm,p-C6H13N1O4
  84.0442084 999.0000 84.044415 6.9130 40.93 0.7333 10 f{C4H6N1O1}/-2.16ppm,p-C6H14N2O3
  101.0700688 121.8465 101.070356 13.2383 76.57 0.2928 8 f{C4H9N2O1}/-8.61ppm,p-C6H11N1O3
  118.0858146 221.5371 118.086196 5.6654 76.25 0.6000 10 f{C5H12N1O2}/-3.73ppm,p-C5H8N2O2
  138.0921863 105.8685 138.092695 23.1222 59.98 0.1359 8 f{C8H12N1O1}/6.13ppm,p-C2H8N2O3
  182.1300239 158.7165 182.131027 16.4114 70.92 0.7547 10 f{C9H16N3O1}/6.78ppm,p-C1H4O3
  183.1133552 237.5451 183.114374 9.5460 81.00 0.6342 10 f{C9H15N2O2}/3.01ppm,p-C1H5N1O2
  228.1349853 146.6651 228.136839 12.1463 75.56 0.5630 9 f{C10H18N3O3}/3.14ppm,p-H2O1
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  55.053677 74.23 74
  56.048779 124.17 124
  72.080688 685.82 685
  83.060357 935.31 935
  84.044208 999.00 999
  101.070069 121.85 121
  118.085815 221.54 221
  138.092186 105.87 105
  182.130024 158.72 158
  183.113355 237.55 237
  228.134985 146.67 146
//
